• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver.2型糖尿病合并非酒精性脂肪性肝病的临床病理特征及相关危险因素
Pak J Med Sci. 2022 Sep-Oct;38(7):1771-1775. doi: 10.12669/pjms.38.7.6289.
2
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
3
Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.2型糖尿病患者血糖、血清趋化素与胰岛素抵抗和非酒精性脂肪性肝病的相关性
Exp Ther Med. 2018 Mar;15(3):2936-2940. doi: 10.3892/etm.2018.5753. Epub 2018 Jan 16.
4
[Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].2型糖尿病患者发生非酒精性脂肪肝的代谢危险因素分析
Zhonghua Gan Zang Bing Za Zhi. 2014 Aug;22(8):631-5. doi: 10.3760/cma.j.issn.1007-3418.2014.08.016.
5
The Risk Factor Analysis for Type 2 Diabetes Mellitus Patients with Nonalcoholic Fatty Liver Disease and Positive Correlation with Serum Uric Acid.2型糖尿病合并非酒精性脂肪性肝病患者的危险因素分析及与血清尿酸的正相关性
Cell Biochem Biophys. 2015 Jul;72(3):643-7. doi: 10.1007/s12013-014-0346-1.
6
Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.中国人 2 型糖尿病患者抵抗素+299A/A 基因型与非酒精性脂肪性肝病的关系。
Gene. 2013 Oct 25;529(2):340-4. doi: 10.1016/j.gene.2013.08.001. Epub 2013 Aug 14.
7
Risk Factors for Nonalcoholic Fatty Liver Disease in Postmenopausal Women with Type 2 Diabetes Mellitus and the Correlation with Bone Mineral Density at Different Locations.2型糖尿病绝经后女性非酒精性脂肪性肝病的危险因素及其与不同部位骨密度的相关性
Diabetes Metab Syndr Obes. 2022 Jun 21;15:1925-1934. doi: 10.2147/DMSO.S364804. eCollection 2022.
8
Correlation of CD3+/CD4+, and serum CK-18 fragment levels with glucose and lipid metabolism in elderly type 2 diabetes patients with nonalcoholic fatty liver disease.老年2型糖尿病合并非酒精性脂肪性肝病患者CD3⁺/CD4⁺与血清CK - 18片段水平与糖脂代谢的相关性
Am J Transl Res. 2021 Apr 15;13(4):2546-2554. eCollection 2021.
9
Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.脂肪细胞型脂肪酸结合蛋白和肿瘤坏死因子-α在2型糖尿病合并非酒精性脂肪性肝病中的作用
Genet Mol Res. 2015 Apr 10;14(2):2940-6. doi: 10.4238/2015.April.10.1.
10
Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.肥胖与非酒精性脂肪性肝病对2型糖尿病发病率影响的比较。
World J Gastroenterol. 2015 Aug 28;21(32):9607-13. doi: 10.3748/wjg.v21.i32.9607.

引用本文的文献

1
The interplay between diabetes and non-alcoholic fatty liver disease: a cross-sectional study from Pakistan.糖尿病与非酒精性脂肪性肝病之间的相互作用:一项来自巴基斯坦的横断面研究。
Ann Med Surg (Lond). 2024 Feb 28;86(4):1929-1932. doi: 10.1097/MS9.0000000000001875. eCollection 2024 Apr.
2
Metformin versus sodium glucose co-transporters inhibitors as first-line for atherosclerotic cardiovascular disease: A meta-analysis.二甲双胍与钠-葡萄糖协同转运蛋白抑制剂作为动脉粥样硬化性心血管疾病一线治疗药物的比较:一项荟萃分析。
Pak J Med Sci. 2024 Jan-Feb;40(1Part-I):209-213. doi: 10.12669/pjms.40.1.6982.
3
Non-Alcoholic Fatty Liver Disease or Type 2 Diabetes Mellitus-The Chicken or the Egg Dilemma.非酒精性脂肪性肝病还是2型糖尿病——先有鸡还是先有蛋的困境。
Biomedicines. 2023 Apr 4;11(4):1097. doi: 10.3390/biomedicines11041097.

本文引用的文献

1
Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial.聚焦超声空化联合有氧运动对非酒精性脂肪性肝病患者腹部及肝内脂肪的影响:一项随机对照试验。
PLoS One. 2021 Apr 28;16(4):e0250337. doi: 10.1371/journal.pone.0250337. eCollection 2021.
2
Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients.2型糖尿病患者的肠道微生物群与非酒精性脂肪性肝病严重程度
J Pers Med. 2021 Mar 23;11(3):238. doi: 10.3390/jpm11030238.
3
Serum uric acid is positively associated with the prevalence of nonalcoholic fatty liver in non-obese type 2 diabetes patients in a Chinese population.在中国人群中,血清尿酸与非肥胖2型糖尿病患者的非酒精性脂肪肝患病率呈正相关。
J Diabetes Complications. 2021 May;35(5):107874. doi: 10.1016/j.jdiacomp.2021.107874. Epub 2021 Feb 16.
4
A look to the future in non-alcoholic fatty liver disease: Are glucagon-like peptide-1 analogues or sodium-glucose co-transporter-2 inhibitors the answer?展望非酒精性脂肪性肝病的未来:胰高血糖素样肽-1 类似物或钠-葡萄糖协同转运蛋白 2 抑制剂是答案吗?
Diabetes Obes Metab. 2020 Dec;22(12):2227-2240. doi: 10.1111/dom.14196. Epub 2020 Oct 6.
5
Pharmacokinetic and metabolomic analyses of Mangiferin calcium salt in rat models of type 2 diabetes and non-alcoholic fatty liver disease.芒果苷钙盐在2型糖尿病和非酒精性脂肪性肝病大鼠模型中的药代动力学和代谢组学分析
BMC Pharmacol Toxicol. 2020 Aug 6;21(1):59. doi: 10.1186/s40360-020-00438-x.
6
Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes.非酒精性脂肪性肝病与老年糖尿病患者
Clin Geriatr Med. 2020 Aug;36(3):527-547. doi: 10.1016/j.cger.2020.04.010. Epub 2020 Apr 17.
7
Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes.骨折风险评估工具可能无法提示 2 型糖尿病女性的骨骼脆弱性。
Am J Med Sci. 2020 Nov;360(5):552-559. doi: 10.1016/j.amjms.2020.04.002. Epub 2020 Apr 11.
8
Is it time for non-alcoholic fatty liver disease screening in patients with type 2 diabetes mellitus?2型糖尿病患者是否到了进行非酒精性脂肪性肝病筛查的时候?
Hepatobiliary Surg Nutr. 2020 Apr;9(2):239-241. doi: 10.21037/hbsn.2019.10.21.
9
Metabolic risk factors and incident advanced liver disease in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of population-based observational studies.代谢风险因素与非酒精性脂肪性肝病(NAFLD)患者发生进展性肝疾病的关系:基于人群的观察性研究的系统评价和荟萃分析。
PLoS Med. 2020 Apr 30;17(4):e1003100. doi: 10.1371/journal.pmed.1003100. eCollection 2020 Apr.
10
Association of liver biomarkers and cytokeratin-18 in Nonalcoholic fatty liver disease patients.非酒精性脂肪性肝病患者肝脏生物标志物与细胞角蛋白-18的关联
Pak J Med Sci. 2020 Mar-Apr;36(3):387-390. doi: 10.12669/pjms.36.3.1674.

2型糖尿病合并非酒精性脂肪性肝病的临床病理特征及相关危险因素

Clinico-pathological features and related risk factors of Type-2 diabetes mellitus complicated with nonalcoholic fatty liver.

作者信息

Chen Lisha, Jiang Li

机构信息

Lisha Chen, Department of Infectious Diseases, Wenling First People's Hospital, Wenling 317500, Zhejiang Province, P.R. China.

Li Jiang, Department of Infectious Diseases, Wenling First People's Hospital, Wenling 317500, Zhejiang Province, P.R. China.

出版信息

Pak J Med Sci. 2022 Sep-Oct;38(7):1771-1775. doi: 10.12669/pjms.38.7.6289.

DOI:10.12669/pjms.38.7.6289
PMID:36246713
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9532671/
Abstract

OBJECTIVES

To analyze the clinicopathological features and risk factors of Type-2 diabetes mellitus (T2DM) patients with non-alcoholic fatty liver disease (NAFLD).

METHODS

The data of 145 patients with T2DM who received treatment in our hospital from May 2020 to May 2021 were collected. The patients were diagnosed with NAFLD by abdominal liver Doppler ultrasound; The general data and laboratory examination indexes of T2DM patients with and without NAFLD were compared; To analyze the risk factors of NAFLD in T2DM patients.

RESULTS

According to the results of the ultrasound examination, 71(48.97%) patients were simple T2DM, and 74(51.03%) patients were T2DM with NAFLD. Compared with simple T2DM, T2DM patients with NAFLD had higher BMI, hypertension, fasting plasma glucose(FPG), insulin resistance, triglycerides (TG), alanine aminotransferase (ALT), aspartate aminotransferase (AST) and uric acid(UA) (<0.05). Further logistic regression analysis showed a higher BMI (=1.841, =0.013), FPG (=1.576, =0.014), insulin resistance (=4.195, <0.001) and elevated TG (=4.676, =0.042) are risk factors for T2DM with NAFLD.

CONCLUSION

High BMI, BPG, insulin resistance index and TG are independent risk factors for nonalcoholic fatty liver in T2DM patients. During intervention, attention should be paid to the monitoring of these indicators to effectively prevent the aggravation of the disease.

摘要

目的

分析2型糖尿病(T2DM)合并非酒精性脂肪性肝病(NAFLD)患者的临床病理特征及危险因素。

方法

收集2020年5月至2021年5月在我院接受治疗的145例T2DM患者的数据。通过腹部肝脏多普勒超声诊断患者是否患有NAFLD;比较合并和未合并NAFLD的T2DM患者的一般资料和实验室检查指标;分析T2DM患者发生NAFLD的危险因素。

结果

根据超声检查结果,71例(48.97%)患者为单纯T2DM,74例(51.03%)患者为T2DM合并NAFLD。与单纯T2DM相比,T2DM合并NAFLD患者的体重指数、高血压、空腹血糖(FPG)、胰岛素抵抗、甘油三酯(TG)、丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)和尿酸(UA)更高(<0.05)。进一步的逻辑回归分析显示,较高的体重指数(=1.841,=0.013)、FPG(=1.576,=0.014)、胰岛素抵抗(=4.195,<0.001)和升高的TG(=4.676,=0.042)是T2DM合并NAFLD的危险因素。

结论

高体重指数、BPG、胰岛素抵抗指数和TG是T2DM患者非酒精性脂肪肝的独立危险因素。在干预过程中,应注意对这些指标的监测,以有效预防疾病加重。